Jefferies Financial Group Reaffirms “Buy” Rating for Target Healthcare REIT (LON:THRL)

Target Healthcare REIT (LON:THRL)‘s stock had its “buy” rating reiterated by equities researchers at Jefferies Financial Group in a report released on Thursday, October 15th, Digital Look reports. They currently have a GBX 124 price objective on the stock. Jefferies Financial Group‘s target price points to a potential upside of 8.20% from the stock’s current price.

Target Healthcare REIT Price Performance

Shares of THRL stock traded down GBX 1.40 during trading hours on Thursday, reaching GBX 114.60. The company had a trading volume of 1,270,746 shares, compared to its average volume of 4,580,919. The company has a market cap of £710.79 million, a price-to-earnings ratio of 8.60, a price-to-earnings-growth ratio of 1.48 and a beta of 0.71. The business has a fifty day simple moving average of GBX 112.07 and a 200-day simple moving average of GBX 109.58. Target Healthcare REIT has a 12 month low of GBX 92 and a 12 month high of GBX 117.

Target Healthcare REIT (LON:THRL) last issued its earnings results on Wednesday, September 23rd. The company reported GBX 13.32 earnings per share (EPS) for the quarter. Target Healthcare REIT had a net margin of 114.60% and a return on equity of 11.03%. On average, equities research analysts expect that Target Healthcare REIT will post 6.22 earnings per share for the current year.

Target Healthcare REIT Company Profile

Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes.